Fundraising Fox

Adaptive Phage Therapeutics

Gaithersburg, US · Founded 2017 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

EL
Evan LohDirector
GL
Gregory L. MerrilExecutive Officer, Director, Promoter
JL
Jonathan LeffDirector
JJ
Jana JensenDirector
RL
Raymond L. MartzDirector
CR
Carl R. MerrilExecutive Officer, Director

Investors · 2

AMR Action FundreportedBostonvia Martin Heidecker · board
Sofinnova VenturesreportedMenlo Park · $100K – $15Mvia Jonathan Leff · board

Reported raises · per SEC filings

Form D private placements
▶$12MraisedJun 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan LeffDirector
  • Jana JensenDirector
  • Carl R. MerrilDirector
  • Ian HardyDirector
  • Michael OrndorffExecutive Officer
  • Gregory L. MerrilExecutive Officer, Director, Promoter
  • Jesse GoodmanDirector
  • Raymond L. MartzDirector
  • Martin HeideckerDirector
  • Evan LohDirector
  • Subhendu BasuExecutive Officer
Offering amount
$30M
Amount sold
$12M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.3MraisedMay 2021 · 59 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Evan LohDirector
  • Gregory L. MerrilExecutive Officer, Director, Promoter
  • Jonathan LeffDirector
  • Jana JensenDirector
  • Raymond L. MartzDirector
  • Carl R. MerrilExecutive Officer, Director
Offering amount
$53.3M
Amount sold
$23.3M
First sale
May 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MofferedAug 2020 · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Subhendu BasuExecutive Officer
  • Gregory Louis MerrilExecutive Officer, Director
  • Carl MerrilExecutive Officer, Director
  • Raymond MartzDirector
Offering amount
$3.6M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$2.8MraisedJun 2020 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory Louis MerrilExecutive Officer, Director
Offering amount
$7M
Amount sold
$2.8M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedNov 2019 · 40 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory Louis MerrilExecutive Officer, Director
  • Raymond MartzDirector
  • Carl MerrilExecutive Officer, Director
Offering amount
$7M
Amount sold
$7M
First sale
Jan 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$765KraisedApr 2017 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory MerrilExecutive Officer, Director
Offering amount
$3M
Amount sold
$765K
Minimum investment
$10K
First sale
Feb 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.